| Quote | Spy RHHBY NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Analyst Upgrades, Downgrades and Initiations: AOL, DWA, EMS, MET, OCNW, SYNA, V, WU ...
BHP SYNA IEX RTP PKX RHHBY ITG MWW KBW MET OCNW CYCC DWA EMS WU SEP G V AOL Linked by BloggingStocks - February 04, 11:40AM from (www.bloggingstocks.com) Analyst Upgrades Barclays upgraded Visa (V) to overweight from equal weight following the Q1 report and guidance. The firm raised its target to $97 from $91. more ...
Swine Flu Antiviral Helps BioCryst Crush Estimates in Q4
BCRX APT RHHBY NVAX INO GNBT SVA NVS SNY Linked by tickerspy blog - February 04, 10:35AM from (www.tickerspy.com) While select swine flu players have seen their pops and drops, BioCryst Pharmaceuticals (BCRX) may have emerged as the small-cap champion of the 2009 pandemic. more ...
Analyst Upgrades, Downgrades and Initiations: ARM, KFT, LOW, OXY, UBS, UPS, VRSN ...
LOW MYL BCS HD SIVB ABX OXY MTN MAN RHHBY CITP VRSN BXP CHRW UPS KFT ARM UBS KNXA CCH Linked by BloggingStocks - February 03, 11:00AM from (www.bloggingstocks.com) Analyst Upgrades Deutsche Bank upgraded United Parcel Service (UPS) to buy from hold on expectations the more ...
Score One for the GOP, Healthcare Sector
MRK PFE AZN RHHBY SNY GSK Linked by tickerspy blog - January 20, 08:56AM from (www.tickerspy.com) Yesterday we covered the Chilean reaction to a market-friendly presidential election, but back in the States, stocks called more ...
Brown Win Boosts Big Pharma
NVO RHHBY SHPGY SNYNF Linked by Forbes - January 20, 07:44AM from (www.forbes.com) European pharmaceutical stocks are getting a lift from the Scott Brown's Senate victory. more ...
Swine Flu Vaccine News Back From the Dead
BAX VICL RHHBY HEB NVAX DVAX INO GNBT NVS GSK Linked by tickerspy blog - December 29, 09:13AM from (www.tickerspy.com) After rocketing higher during yesterday's session, swine flu news is helping vaccine maker Vical (VICL) higher Tuesday. more ...
Europe Gains A Second Day
BCS RBS AZN RHHBY SHPGY MCO NVS GSK Linked by Forbes - December 22, 06:13AM from (www.forbes.com) Leading shares tick higher, with financials leading the way, ahead of a stream of U.S. macroeconomic data on Tuesday. more ...
Big Pullback for Top Swine Flu Small-Caps
VICL BCRX APT RHHBY DVAX SVA NVS GSK Linked by tickerspy blog - November 17, 12:18PM from (www.tickerspy.com) The H1N1 vaccine sector slipped on Tuesday, with some of the less speculative names being hit the worst. more ...
The $2000 Swine Flu Drug
BAX GILD BCRX APT RHHBY HEB DVAX INO SVA Linked by tickerspy blog - November 05, 09:53AM from (www.tickerspy.com) The peramivir pricing speculation is over, and the first order has been shipped. The U.S. FDA issued more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2010 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|